If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
656.00    -2.00 (-0.30%)
Bid:
655.00
Ask:
657.00
Spread: 2.00 (0.305%)
Market Cap: £571.54m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Directorate Change

31 Jan 2014 15:30

RNS Number : 9779Y
Victrex PLC
31 January 2014
 



 

31 January 2014

 

Victrex PLC("the Company")

 

Directorate Change - Confirmation of future payments

 

Further to our announcement of 7th November 2013 and our 2013 Annual Report & Accounts, Victrex plc confirms the following details in relation to future payments to Steve Barrow, who steps down from the Board of Victrex today:

 

· a payment of salary in lieu of notice will be payable to reflect the unexpired portion of the 12 month notice period, which commenced on 7 November 2013. Based on a cessation date of 31 May 2014 the payment, which is subject to mitigation in the event of alternative employment, will be £107,862. This amount will be paid on or before 30 May 2014 as a lump sum;

 

· there will be no entitlement to an annual bonus or long-term incentive award for the 2014 financial year;

 

· from 10th February, he will become a deferred member of the pension scheme and will receive a payment equivalent to the employer contribution until his date of departure on 31 May 2014. In addition, he will continue to receive the existing pension supplement until this date;

 

· the treatment of long-term incentive awards which were unvested at the time of the 7th November 2013 announcement is as follows:

 

Grant

Date

End of Performance Period

Shares under award

Normal Vesting date

Approach

Treatment

16/02/09

30/09/11

15,121

16/02/14

Default*

 

 

To vest on normal vesting date

14/12/09

 

30/09/12

 

4,596

14/12/13

Default*

 

 Vested on normal vesting date

 

4,596

14/12/14

Good leaver**

 To vest on normal vesting date

 

13/12/10

 

30/09/13

 

432

13/12/13

Default*

 

 Vested on normal vesting date

 

432

13/12/14

 

Good leaver**

 To vest on normal vesting date

 

431

13/12/15

 To vest on normal vesting date

 

12/12/11

30/09/14

21,622

N/A

Default*

 

To lapse in full at cessation

 

12/12/12

30/09/15

15,840

N/A

To lapse in full at cessation

 

* Default treatment under the plan rules

** Good leaver treatment applied given the performance period has been completed

 

Further details in respect of the number and value of shares received under the long-term incentive awards will be disclosed in future remuneration reports.

 

Contact:

Suzana Koncarevic

General Counsel and Company Secretary

+ 44 (0) 1253 898 067

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEANFFDLFLEEF
Date   Source Headline
9th Jul 20251:02 pmRNSHolding(s) in Company
8th Jul 20253:33 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSDirectorate change: CEO succession
8th Jul 20257:00 amRNSQ3 Trading Update
30th Jun 20251:38 pmRNSTotal Voting Rights
30th Jun 20259:13 amRNSDirector Declaration
18th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
3rd Jun 20251:56 pmRNSHolding(s) in Company
2nd Jun 202511:34 amRNSBlock listing Interim Review
2nd Jun 202510:25 amRNSHolding(s) in Company
30th May 20259:50 amRNSTotal Voting Rights
27th May 202512:40 pmRNSHolding(s) in Company
13th May 20253:30 pmRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSVictrex plc – Interim Results 2025
7th May 20257:00 amRNS‘Magma’ advances via TechnipFMC award
30th Apr 202511:00 amRNSTotal Voting Rights
31st Mar 20259:17 amRNSTotal Voting Rights
21st Mar 202510:34 amRNSDirector/PDMR Shareholding
28th Feb 20259:55 amRNSTotal Voting Rights
19th Feb 20259:00 amRNSAdditional Listing
7th Feb 20251:54 pmRNSResult of AGM
7th Feb 20257:00 amRNSAGM and Trading Update
31st Jan 20259:17 amRNSTotal Voting Rights
21st Jan 20251:56 pmRNSHolding(s) in Company
6th Jan 20251:00 pmRNSAnnual Financial Report
31st Dec 20249:00 amRNSTotal Voting Rights
16th Dec 20248:52 amRNSDirector/PDMR Shareholding
11th Dec 20243:07 pmRNSDirector/PDMR Shareholding
10th Dec 202411:46 amRNSDirector/PDMR Shareholding
10th Dec 20249:28 amRNSHolding(s) in Company
3rd Dec 202410:58 amRNSDirector/PDMR Shareholding
3rd Dec 20247:00 amRNSVictrex plc - Preliminary Results 2024
2nd Dec 20249:38 amRNSBlock listing Interim Review
29th Nov 20249:07 amRNSTotal Voting Rights
14th Nov 20249:31 amRNSHolding(s) in Company
31st Oct 202412:25 pmRNSTotal Voting Rights
14th Oct 20243:09 pmRNSHolding(s) in Company
30th Sep 20241:44 pmRNSTotal Voting Rights
27th Sep 20249:22 amRNSHolding(s) in Company
24th Sep 202411:24 amRNSDirector/PDMR Shareholding
17th Sep 20242:00 pmRNSUS FDA approval: Total Knee Study
12th Sep 202411:18 amRNSDirector/PDMR Shareholding
3rd Sep 20244:20 pmRNSHolding(s) in Company
30th Aug 20243:44 pmRNSDirector/PDMR Shareholding
30th Aug 20249:16 amRNSTotal Voting Rights
23rd Aug 20243:18 pmRNSHolding(s) in Company
9th Aug 202410:08 amRNSHolding(s) in Company
5th Aug 20241:56 pmRNSDirector/PDMR Shareholding
2nd Aug 202411:51 amRNSDirector/PDMR Shareholding
1st Aug 20241:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.